ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 641454 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 641454; 2) Community: the network communities that were significantly associated with the response to NSC 641454; 3) Molecule: the relationships between components within communities and NSC 641454; 4) MDR: the compounds that were significantly associated with the NSC 641454.

NSC Compound Enrichment Correlation
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0378615809326464 0.13820466
NSC 629595 Null 0.0378615809326464 0.28673367
NSC 633113 [1,2,3,4]Tetrathiocino[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetraethyl-1,2,3,8,9,10-hexahydro- 0.0378615809326464 0.22888035
NSC 104942 EUPAROTIN 0.0385613993886001 0.1326434
NSC 119875 Cisplatin 0.0385613993886001 0.38910728
NSC 121713 Null 0.0385613993886001 0.39198014
NSC 13318 Null 0.0385613993886001 0.32111579
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0385613993886001 0.48463921
NSC 274553 Null 0.0385613993886001 0.19524026
NSC 48648 Null 0.0385613993886001 0.076309588
Total:79  Current:61    [First] [Prev] [Next] [Last]